This trial is testing whether a new assessment tool, the LuxIQ/2, is better than the current standard (the OttLite Cobra) at determining which combination of colored filters and illumination intensity is best for patients with low vision.
2 Primary · 2 Secondary · Reporting Duration: 12 weeks
50 Total Participants · 1 Treatment Group
Primary Treatment: Colored near reading glasses · No Placebo Group · N/A
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|Nova Southeastern University||100.0%|